Avalo Therapeutics, Inc. - Common Stock —— 季度现金流量表 (NASDAQ:AVTX) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 150.73 M138.52 M126.58 M125.1 M116.46 M99.89 M 负债总额 17.7 M15.91 M22.01 M33.55 M33.41 M31.57 M 权益总额 133.03 M122.61 M104.57 M91.55 M83.05 M68.32 M 负债及股东权益总额 150.73 M138.52 M126.58 M125.1 M116.46 M99.89 M 总债务 —————— 净债务 ——————

新闻

This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout

CORT Rises on FDA Nod to Lifyorli in Platinum-Resistant Ovarian Cancer

根据BTIG分析的今年顶级医疗保健股票

Top Healthcare Stocks for This Year According to BTIG

Avalo Therapeutics Stock Has More Than 200% Upside? Analyst Breaks Down Bull And Bear Case - Avalo Therapeutics (NASDAQ:AVTX)

谷根海姆给予Avalo Therapeutics买入评级，股价盘前上涨

Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating

古根海姆以IL-1β疗法为由对Avalo Therapeutics股票给予买入评级

Guggenheim initiates Avalo Therapeutics stock with Buy rating on IL-1β therapy

Avalo Therapeutics股票在试验数据发布前维持H.C. Wainwright买入评级

Avalo Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of trial data

This Valvoline Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Avalo Therapeutics (NASDAQ:AVTX), Lexeo Therapeutics (NASDAQ:LXEO)